Servizio di medicina preventiva che combina test del sangue su 115+ biomarcatori, AI e medici di base assegnati.
| Date | Round | Amount |
|---|---|---|
| Jan 2026 | Pre Seed UK-based Emerald added $1.2 million to its pre-seed ($2 million total) led by Boost Capital Partners for its service combining blood testing, AI and medical care. | $1.2M |